Advertise on podcast: Cannabis Legalization News Podcast

Send us Fan Mail On 420 Eve, Tom and co-host discuss cannabis legalization news, arguing the IRS is the main federal agency still enforcing marijuana laws through IRC 280E, including an IRS clarification that the “no tax on tips” deduction doesn’t apply to cannabis workers like budtenders. They cover a hot-mic clip of Trump joking that DOJ is “slow walking” rescheduling, and compare broader non-enforcement by agencies like the FDA. The episode highlights Illinois delays with $40 million in promised social equity loans for 166 licensees as they struggle to open a regulated dispensary with costly requirements like full-time security, vault rules, and limited product display. Other topics include Rhode Island’s residency-requirement lawsuit delaying licensing, tariffs raising RAW rolling machine costs, a Canadian-structured cannabis company using Chapter 15 bankruptcy, Maryland and Oregon medical cannabis bills (pets and hospitalized kids), Texas hemp litigation, Virginia retail delays, and a Singapore execution for cannabis trafficking. 00:00 Show Intro and Headlines 00:53 420 Eve and Hemp Loopholes 02:01 IRS and No Tip Tax 03:06 Cannabis Culture and Activism 04:19 Trump Rogan Rescheduling Clip 06:06 Illinois Equity Loans Delayed 07:02 Hemp Influencers and Real Rules 13:01 Dispensary Build Compliance Grind 13:54 Vaults Security and Tech Stack 17:36 Rhode Island Licensing Blocked 19:29 Regulation vs Open Markets 22:16 Where Did the Culture Go 24:59 Manifesto for the Normies 25:48 Absurd Cannabis Laws 26:27 Hemp Versus Weed Divide 27:03 Canadian Bankruptcy Loophole 29:56 Debt Restructuring Basics 32:12 Puppies Kids And Cannabis 33:56 420 Store Prep Struggles 36:25 Colorado Tax Overhaul Talk 37:29 Hemp Confusion And Politics 39:58 Virginia Texas And Crackdowns 42:02 Global Penalties And 420 Sales 46:47 Kentucky Hemp Drink Rules 48:46 Live Pod Sign Off Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The hosts discuss cannabis legalization news dated April 12, 2026, focusing on a Texas judge granting an injunction affecting hemp/THCA policy ahead of 4/20 and an Ohio judge ruling that Ohio’s hemp restrictions are discriminatory because intoxicating cannabinoids can be sold through licensed marijuana channels but not ordinary retail when derived from hemp. They argue hemp loopholes (Delta-9/THCA) created bad policy and market chaos, cite enforcement issues like a large hemp shipment being stopped at a FedEx center, and predict the “civil war” between hemp and regulated cannabis will end as loopholes close. They say marijuana Schedule III rescheduling is being held up in the White House, reference Roger Stone’s claim about internal blocking, and express skepticism it will move under Trump. They also warn Virginia’s coming licensing lottery will be cash- and timeline-intensive, note Pennsylvania Governor Shapiro’s projected $1.3B plan faces a Republican Senate, and mention North Carolina’s advisory report estimating a $2.2B unregulated market. 00:00 Welcome And Headlines 00:36 Newsletter And Story Rundown 04:56 Texas Hemp Injunction Explained 07:50 Shipping Loopholes And Rescheduling Doubts 09:54 Virginia Licensing Reality Check 13:36 Ohio Hemp Ruling And THCA Science 17:13 Schedule Three Stalled Politics 20:00 Illinois Policy Nonsense And PA Budget Pitch 23:16 Strain Names Teaser 23:37 Viral Strain Breakdown 24:35 Trust and Online Hype 26:04 Hemp Loophole Fallout 27:50 Licensing Lawsuit Reality 29:28 Funding Social Equity Dreams 33:22 Branding Rules by State 36:59 Dispensary Build Grind 38:24 North Carolina Market Push 40:02 Stigma and Medical Future 42:34 420 Plans and Wrap Up Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The hosts recap a chaotic first week of April 2026 cannabis headlines, clarifying their April Fools clickbait about federal legalization and focusing on real developments: a new CMS/Medicare CBD program tied to the Commonwealth Project and Howard Kessler that offers limited oral-only low-THC/CBD coverage through a small number of approved vendor networks, alongside FDA non-enforcement despite federal-law conflicts; a lawsuit seeking to stop the program had its TRO denied with another hearing slated for late April. They discuss hemp restrictions taking effect March 31 (including Texas), South Carolina indictments over marijuana/THC products, a challenge to Michigan’s new wholesale marijuana tax, and Georgia’s bipartisan medical cannabis expansion removing a 5% THC cap, adding vapes for 21+, and expanding qualifying conditions. The conversation also covers frustrations with Illinois social equity loans and dispensary delays, skepticism about certain licensing lawsuits, Virginia rollout concerns, and ends with a Howard Law Group promotion for cannabis transactions and litigation. 00:00 April Fools Headlines 01:53 Medicare CBD Rollout 04:41 Why Seniors Only 05:58 AI Video Backlash 09:59 Dispensary Money Crunch 11:07 Lawsuit And FDA Memo 14:46 Hemp Kids And YouTube 19:05 Pam Bondi Fired 20:52 Michigan Tax Lawsuit 22:02 Illinois Hemp Politics 25:20 Georgia Medical Expansion 28:17 Alcohol Versus Cannabis 30:09 Brands Closing Down 30:31 Marketing Rules Reality 31:37 Weed Normalization Debate 32:55 Virginia Rollout Critique 36:22 Funding Zoning Barriers 38:28 Social Equity vs MSOs 41:16 Illinois Lawsuit Hot Take 43:35 Delivery IP and Hemp 48:07 Investing Options Basics 53:24 Texas and State Crackdowns 55:05 Illinois Loans Frustration 57:30 Howard Law Group Outro Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail Illinois Social Equity Loan Delays, Hemp/THC Crackdowns, and Shifting Federal-State Cannabis Policy The episode reviews cannabis legalization news while focusing on Illinois’s stalled social equity loan program: about 160+ applicants sought a $40 million fund, were promised decisions by January then delayed into spring, and the hosts argue the Illinois DCEO’s inaction is pushing operators into defaults, forcing fronted rent and buildout costs, and potentially prompting Court of Claims litigation. They discuss broader regulatory frustration, contrasting state bureaucracy with perceived federal movement, including a planned federal/CMS-style CBD product coverage pilot with strict THC caps that tighten further in November, plus concerns about bans and limits on inhalables/flower and full-spectrum CBD. The hosts anticipate Texas lawsuits over impending hemp/THCA restrictions, note Missouri’s cease-and-desist actions and microbusiness losses, cover South Carolina’s THC beverage bill limits, mention Idaho’s medical marijuana ballot signature progress, and promote ACPrivilege.ai for non-discoverable AI legal queries and Collateral Base consulting. 00:00 Going Live Intro 00:05 Illinois Loan Delays 02:02 Equity Program Breakdown 03:43 Hemp Loopholes Backlash 05:34 Federal CBD Crackdown 07:38 Dispensary Cash Crunch 10:01 Texas Lawsuit Countdown 12:53 Bureaucrats vs Entrepreneurs 15:30 Missouri Hemp Enforcement 18:49 Illinois Politics and Hemp 20:14 White House Policy Meeting 26:13 Science Standards and Consumers 27:53 What Being High Means 28:58 Deportations Over Weed 29:27 South Carolina THC Drinks 31:36 Hemp Loopholes and Factions 34:57 CBD Medicare Subsidy Debate 39:13 Trolls and Cannabis Risks 43:22 Minnesota Policy Stalls 45:20 Medical Program Failures 48:00 Idaho Ballot Push 48:50 AI Privilege Legal Tool 54:10 Collateral Base Closing Ad Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail Tom hosts another episode of Cannabis Legalization News, recapping the week’s major policy and market developments. The show covers the newly introduced bipartisan CLIMB Act (Capital Lending and Investment for Marijuana Businesses Act), which would provide safe harbor for U.S. stock exchanges and market participants to list and trade cannabis-related securities. They discuss reports that “Pot Inc.” is poised to benefit from President Trump’s marijuana reclassification directive, but that DOJ—under Pam Bondi—has no deadline and is still working through a complicated internal process, while rescheduling alone won’t create a full regulatory framework. The episode also reviews CMS/Medicare guidance moving toward coverage of certain hemp-derived full-spectrum CBD edibles with strict limits (under 3 mg THC per serving, later tightening), benefiting companies like Charlotte’s Web. Additional topics include a CRS rescheduling update, state-level restrictions, Virginia adult-use timing, dispensary build-out/financing realities, and cannabis marketing limits. 00:00 Welcome and Week Ahead 02:01 Climb Act Wall Street Access 03:50 Politics Gas and Gripes 05:06 Trump Reclassification Watch 06:55 CMS Hemp CBD Rules 09:35 Charlotte's Web Stock Surge 12:41 CRS Rescheduling Update 16:42 State Markets and Homegrow 20:46 DEA Data Youth Use Down 22:45 State Legislation Virginia Focus 26:40 Ballot Rules Block Legalization 28:13 Verano Loan Breakdown 29:54 Building a Brand Lounge 31:09 Amazon Style Ad Revenue 32:08 Regulatory Steps and Loans 32:44 Wisconsin Hemp Guardrails 33:54 Why Dispensaries Take Years 37:43 Strain Talk Ridgeline Runtz 39:18 AI Tools and Weed Blog 42:08 Interstate Commerce and Branding 45:15 Pricing Menus and Market Fit 46:53 Missouri Expansion and Exit Strategy 48:36 Wrap Up and Legal Sponsor Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The hosts discuss cannabis legalization frustrations and preview stories for the week ending March 15, 2026, led by a tax court case tied to roughly $1.6B in MSO 280E-related liability, where the U.S. argues cannabis businesses fall “within the meaning” of Schedule I/II for 2016–2017 tax years, despite the ongoing rescheduling push. They note a Ninth Circuit decision that the dormant Commerce Clause does not apply to cannabis, contrasting with East Coast rulings and a continuing circuit split after the Supreme Court declined review. State updates include Texas’s March 31 ban on smokable hemp/THCA flower sales, Tennessee “pot for potholes” messaging, Virginia’s new micro-vertical licensing framework and regulator setup, Alabama’s medical rollout delays due to litigation, Florida’s ballot initiative setbacks and political hypocrisy, and Verano’s $195M loan amid ongoing MSO expansion. Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail Cannabis Legalization News (Mar 8, 2026): Texas Hemp Crackdown, SCOTUS & 2A, Missouri Rules, Michigan Drama The hosts deliver a casual, no-prep cannabis legalization news roundup dated March 8, 2026, focusing on Texas moving to shut down much of the intoxicating hemp market (with rules nearing publication, limiting THCA flower and vapes), and discuss a Supreme Court case where several justices appeared skeptical of a law barring cannabis users from firearm possession due to a lack of evidence of “dangerousness.” They also cover Kansas Democrats pushing legalization but being blocked by GOP leadership, Nebraska tribe efforts to advance medical cannabis despite state pushback, Missouri’s proposed rules targeting bad actors and ownership misconduct, Michigan’s cannabis tax distributions and a city controversy involving companies paying legal bills, Virginia Tech research on cannabis and driving, Oregon’s failed bill to cap edibles over 10mg THC, Afroman’s lawsuit story, and Michigan guidance on restricted terms like “dispensary.” 00:00 No Prep Cold Open 01:30 Supreme Court Gun Case 05:17 Texas Hemp Rules Crackdown 08:48 Kansas Stalled Legalization 10:38 Nebraska Tribe Pushback 12:52 Smoke Break Sponsor Spot 13:35 Name That Strain Game 14:19 Missouri Targets Bad Actors 16:25 Hemp Loophole Rant 21:02 Michigan Cannabis Taxes 21:41 Live Google Search Wrap 22:27 Hemp Bill Jurisdiction Fight 23:57 Access Limits And Supply 26:05 Security Rules And Politics 27:07 Michigan Legal Bills Scandal 29:57 Virginia Tech Driving Data 31:04 Afroman Raid And Lawsuit 34:19 Oregon Edibles Cap Fails 37:08 Seeds Genetics And Hemp Loopholes 39:40 Michigan Provisioning Centers Meme 42:13 Wrap Up And Sponsor Plug Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail This episode breaks down excerpts from a Supreme Court oral argument about whether federal law 18 USC 922(g)(3) can categorically bar “unlawful” marijuana users from Second Amendment rights under the Bruin historical-tradition test and in light of Rahimi’s dangerousness focus. It highlights Justice Gorsuch questioning whether “habitual user” is defined too loosely compared to historical “habitual drunkard” laws, and similar concerns from Justices Sotomayor and Barrett about whether scheduling decisions reflect individualized dangerousness.  Justice Thomas presses distinctions between marijuana and other drugs (including anabolic steroids) and notes the DEA’s ongoing rescheduling process, while Justice Alito emphasizes the founders’ lack of experience with modern drugs. Justice Kagan poses an ayahuasca hypothetical, and the host predicts a likely 6–3 or 7–2 outcome against the government’s position, with a decision expected by late June. Shout out to this channel, here's the whole thing: https://youtu.be/iMow-Yt1sJo?si=JU1zmjqVxBAgOk_l 00:00 Supreme Court Preview 00:34 Gorsuch Questions Habitual Use 02:14 Founding Era Context 03:57 Sotomayor Ambien Analogy 05:08 Thomas on Illegality 07:24 Alito History Problem 09:01 Kavanaugh Mens Rea 12:13 Gorsuch Rescheduling Pushback 16:19 Barrett Demands Dangerousness 23:15 Jackson on Bruin Limits 25:25 Kagan Ayahuasca Hypothetical 29:02 Predicted Vote Count 30:22 Wrap Up and Sponsor Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The hosts recap a slow week in cannabis legalization news, criticizing Donald Trump’s long State of the Union for omitting cannabis and calling rescheduling progress painfully slow. They discuss an NPR story linking cannabis use and psychosis, arguing association isn’t causation and that legalization with age-gating and product sourcing is a better policy response.  They cover looming changes to the hemp/THCA and seed markets tied to Farm Bill activity and enforcement, and note a Supreme Court review of the federal gun ban for cannabis users, arguing the blanket prohibition is unconstitutional. The episode also updates progress on the hosts’ Pekin Dispensary in Illinois and its website, mentions a lawsuit against ICE arising from a California cannabis raid, highlights illicit grow house raids, references regulatory actions in Michigan, and ends with a “name that strain” segment identifying Strawberry Goo. 00:00 Sunday News Kickoff 00:52 State of the Union Miss 02:14 Why Rescheduling Stalls 04:17 NPR Psychosis Scare 08:02 Farm Bill Hemp Loopholes 09:52 Dispensary Build Update 10:49 Ad Break and Demonetization 11:34 Gun Ban Supreme Court 12:38 Commerce Clause Explained 18:21 Seeds Crackdown Coming 20:18 Hemp Hype vs Real Legalization 24:41 Colorado Oversupply Waste 25:41 Store Website Walkthrough 26:14 Homepage Constraints 26:26 Livestream Freeze Out 27:17 Shop Location Reveal 28:26 Responsive Site Tweaks 29:20 ICE Raid Lawsuit Talk 30:34 Name That Strain 32:36 Flavor Effects Guidance 35:36 Hemp Ban Politics 37:48 Dispensary Ops Automation 40:53 Illegal Grow Raid Laws 44:19 Market Pricing Reality 46:53 Senior Kiosk Idea 48:05 Doctor Immunity Taxes 49:39 Final Regulation Wrap 50:33 Reschedule Closing Ad Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The cannabis world is reeling! House Agriculture Chairman Glenn "GT" Thompson's new Farm Bill draft introduces a "total THC" standard that could ban most hemp products. #cannabisnews #farmbill # 00:00 Farm Bill Markup Tomorrow: What’s Actually Changing? 01:40 Hemp Beverages & Interstate Sales: Why the Loophole Is Closing 02:19 Congress, Tariffs, and Election Chaos: Why Nothing Gets Done 03:54 Inside the New Farm Bill: 0.3% Total THC + Kicking Products to FDA 05:15 Loophole Business vs Real Reform: Rescheduling, Schedule III, and Reality Checks 07:19 Cannabis & Mental Health Studies: Age-Gating as the Legalization Argument 11:02 Seeds, Genetics, and Debanking: The Next Underground Market? 14:41 “Just Legalize It” Isn’t a Plan: Medical Cannabis as the Winning Policy 17:32 Texas Ballot Push + FDA Missed Deadlines: Enforcement vs Banking Reality 21:02 Missouri vs Illinois Hemp Rules + The Politics of Lobbying and ‘Real Change’ 25:33 GOP Congressman Cheers Schedule I: The Next Story Tease 25:58 Why Hemp & Cannabis Reform Keeps Getting Stalled (Andy Harris & House Roadblocks) 26:50 Reschedule vs Deschedule: Building the Whole ‘Staircase’ Without Loopholes 28:28 NBA Player Busted in The Bahamas: Why Legal Markets Mean Safer Access 29:55 Regulated Medical Cannabis: The Only Policy Congress Can Agree On 31:05 Name That Strain: Black Truffle (Terps, THC Myths & Compliance Talk) 35:29 Cannabis Contracts in Federal Court: When ‘Illegal’ Kills Enforcement 40:45 Government-Run Dispensaries & The Backlash: Smell Laws and Public Space 43:29 Gummy Chaos: Dosing a Flight, Edible Limits, and Wild State-by-State Caps 45:43 Activism Reality Check, Wrap-Up, and Store Updates (Logo, Window, Soft Open) want to start your own podcast?  Try StreamYard. Want to create live streams like this? Check out StreamYard: http Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail Tom hosts a live cannabis legalization news show from a soon-to-open dispensary in Pekin, giving a brief tour of the sales floor, ID check area, vault, and planned community space, and noting the shop is expected to open in about three to four weeks after a three-year licensing process. The episode covers the FDA missing a cannabinoid-related deadline while acknowledging marijuana benefits but emphasizing concerns about children; a USDA Farm Bill draft that keeps the hemp definition and does not directly address hemp-derived intoxicating products; and backlash to a New York Times editorial calling for “guardrails” after previously backing legalization, with discussion about confusion between regulated cannabis and unregulated intoxicating hemp. They also mention Ohio Governor Mike DeWine urging people to stop complaining about new adult-use restrictions and a push to ban intoxicating hemp products, while citing developments in Chicago and Missouri and arguing hemp drinks and “marijuana labeled as hemp” will face increasing regulatory and banking pressure. Guest Dr. Riley Kirk (Canna Chem), PhD in pharmaceutical sciences and co-founder of a research/education nonprofit, discusses barriers to cannabis research under Schedule I and how Schedule III could expand research by enabling write-offs and reducing hurdles. She describes her group’s industry-funded work, including “Science of Smokeability,” focused on what makes smokable products high quality and safer. Kirk explains current theories around cannabinoid hyperemesis syndrome (CHS), including her survey-based study of 1,000+ people diagnosed or told they have CHS, common symptoms (notably early-morning nausea), and relief via hot showers linked to TRPV1 activation; she notes competing hypotheses such as high-potency frequent THC use, vaping, genetics, or mycotoxins. 00:00 Live from the Dispensary: Show Kickoff & What’s Coming Up 01:12 Behind the Scenes: Sales Floor Tour, Compliance Rules & Opening Timeline 02:56 FDA Missed the Deadline: Cannabis Benefits, ‘Think of the Children’ & Admin Chaos 05:23 Farm Bill Draft Breakdown: Hemp Definition, Total THC, and What’s (Not) Changing 08:16 Hemp Drinks on Borrowed Time: Enforcement, Banking Risk & Political Reality Check 15:54 Quick Dispensary Walkthrough: Vault Door, Restricted Areas & Build-Out Plans 18:16 Meet Dr. Riley Kirk: Why Cannabis Research Is So Hard (and How It Gets Funded) 22:52 Cannabinoid Hyperemesis Syndrome (CHS): Potency, Vapes, Genetics & Competing Theories 29:08 Endocannabinoid Deficiency & Media Spin: Nuance vs Clickbait Cannabis Headlines 32:46 “We Need More Studies” — ECS, Nervous System & What Science Is Missing 34:15 Aging, Tolerance Shifts & the Entourage Effect Explained 36:21 Homegrow, Trusting Inputs & Why ‘No Flower’ Medical Programs Fail 39:18 Rescheduling to Schedule III: Validation, Pharma Capsules vs Flower 44:39 What Research Is Next: Receptor-Level Effects & Better Strain Profiling 46:47 Strain Spotlight: Gorilla Glue & Building a Flavor-Based ‘Menu’ 49:16 Beyond Terpenes: Flavor Chemistry, Ratio Strains & Fixing THC-Only Marketing 50:59 CBD/CBG Demand, Hemp Market Changes & The Lab Testing Inflation Problem 57:58 Consumer-Friendly Education: Activity-Based Recommendations & 1:1 Strains 01:00:02 How CBD Works (and Why It Can Boost THC Experience) + Final Wrap & Where to Find Canna Chem Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail The FDA is facing a deadline next week to publish three federal cannabinoid lists and to clarify what counts as a hemp product “container” under appropriations legislation President Donald Trump signed last year. Those lists and the “container” guidance are due by Tuesday, and they matter because the law is scheduled to change federal hemp rules in November—shifting from a delta-9 THC standard to “total THC” (including delta-8 and other isomers) and potentially restricting a wide range of consumable cannabinoid products. 00:00 Welcome and Episode Overview 00:59 Super Bowl Sunday Vibes 01:36 FDA's Upcoming Deadline on Hemp Definitions 03:38 Hemp Industry and Legal Confusion 08:43 Cannabis and Hemp Policy Roundtable 12:53 New Member Shoutouts and Upcoming Content 13:54 Legal Challenges and Market Dynamics 26:29 Dispensary Tour and Regulations 28:04 State Security Regulations 28:41 Building Renovations and Compliance 29:08 Cannabis Legalization and Regulations 29:46 Logo Contest and Compliance Challenges 31:05 Federal Security Clearances and Cannabis 32:09 Cannabis and Holistic Wellness 32:54 Cannabis Industry and Legalization Challenges 40:50 Minnesota Cannabis Raid and Legal Battle 42:04 Cannabis Strain Review 45:28 Oklahoma's Black Market Crackdown 50:58 Ohio's Antitrust Lawsuit Against MSOs 55:31 Final Thoughts on Cannabis Policy #CannabisNews #Hemp #FDA #THC #CBD #Delta8 #FarmBill #Cannabinoids #CannabisLegalization want to start your own podcast?  Try StreamYard. Want to create live streams like this? Check out StreamYard: https://streamyard.com/pal/d/5822037327085568 Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail 📰 Free Newsletter – https://bit.ly/3VEn9vu 🧢 CLN Merch https://spreadshop-admin.spreadshirt.... 🤝 Work With Us https://bit.ly/m/collateral-base 👍 Like • 🔔 Subscribe • 💬 Comment: In this educational video, attorney Tom Howard discusses the pivotal Supreme Court case of US v Hemani, which addresses the legality of cannabis users possessing firearms. Starting with background information, Tom covers the specific statute in question, 18 USC 922(g)(3), and its impact on cannabis users. He highlights the procedural history, the current circuit split, and the constitutional tests involved. Tom emphasizes the potential overreach of Congressional law and examines the historical traditions of firearm regulation. The video also delves into related legal considerations and potential outcomes of the case, with oral arguments set for March 2nd. Stay informed, subscribe for more updates, and join the discussion on cannabis legalization and Second Amendment rights. 00:00 Introduction to the Case 00:34 Understanding US v Hemani 00:52 Legal Background and Statutes 01:27 Procedural History and Supreme Court Involvement 02:17 Constitutional and Historical Context 03:11 Implications for Cannabis Users 05:11 Comparisons with Other Substances and Cases 07:53 Policy and Government Actions 09:34 Conclusion and Final Thoughts Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail In this episode, the hosts discuss the current state of cannabis legalization, focusing on its gradual normalization rather than sweeping legislative changes. Key topics include the NRA's alignment with cannabis advocates in a Supreme Court case, the proliferation of hemp THC drinks, and the emergence of city-run dispensaries. The hosts also touch on the evolution of laws regarding cannabis users' Second Amendment rights and the impact of research on cannabis legalization. Highlights also cover regulatory challenges faced by the hemp industry and updates from various states on cannabis policies, including Alabama's controversial bill on cannabis odor and child welfare, and Florida's ongoing legal battles over marijuana possession. 00:00 Introduction to Cannabis Legalization and Normalization 01:12 NRA and Cannabis Advocates Unite 02:27 Cannabis and Firearm Rights Debate 04:59 Opioids and Cannabis: A New Perspective 06:09 Hemp THC Drinks and Market Dynamics 09:11 Challenges in Cannabis Legislation and Market 17:02 Federal Regulations and Hemp Production 19:25 Licensing and Regulation Challenges 21:23 CBD Regulation and Market Dynamics 22:42 State-Specific Cannabis Legislation 24:44 Municipal Control and Market Impact 27:04 Legal and Social Implications 30:02 Industry Trends and Future Outlook 37:43 Concluding Thoughts and Announcements Support the show Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail Navigating the Legal Maze of Schedule Three Cannabis Rescheduling In this special episode of Cannabis Legalization News, the intricate process of moving cannabis to Schedule Three is thoroughly examined. The host breaks down the involved statutes, rules, and legal procedures, including key milestones such as interlocutory appeals, DEA hearings, and the final rescheduling rule. The episode highlights the delays and legal hurdles over recent years, explaining the role of administrative law judges, public comments, and the potential impact of the Congressional Review Act (CRA). The timeline for when cannabis might actually be rescheduled to Schedule Three under federal law is discussed, ranging from late 2026 to potentially 2028, depending on procedural and legal challenges. 00:00 Introduction and Overview 00:06 Current Status of Schedule Three Cannabis 02:03 Legal Procedures and Statutes 03:28 Steps to Reschedule Cannabis 04:30 Interlocutory Appeal and Hearing 06:45 Post-Hearing Procedures 09:49 Congressional Review Act (CRA) 11:47 Judicial Review and Final Thoughts 13:40 Conclusion and Viewer Interaction Support the show Get our newsletter: https://bit.ly/3VEn9vu